Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Supraventricular arrhythmias and left atrial evaluation in athletes by CMR: going beyond the left ventricle.

Journal of science and medicine in sport·2026
Same author

MRI for Acute Pelvic Pain in Pediatric Females After Inconclusive Ultrasound: Diagnostic Performance of Non-Contrast-Enhanced and Contrast-Enhanced Protocols.

Diagnostics (Basel, Switzerland)·2026
Same author

A novel insight into the athlete's heart: Hemodynamic forces evaluation by cardiovascular magnetic resonance.

International journal of cardiology·2025
Same author

ESR Bridges: imaging of cancers in pregnancy-a multidisciplinary view.

European radiology·2025
Same author

Will PET/MR Imaging Replace PET/CT for Pediatric Applications?

Diagnostics (Basel, Switzerland)·2025
Same author

Pediatric Congenital Lung Malformation: Advanced Imaging Techniques in Pre- and Neonatal Evaluation.

Diagnostics (Basel, Switzerland)·2025

相关实验视频

Updated: Jun 20, 2026

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

68 在激进前列腺切除术后复发前列腺癌的Ga-PSMA PET/CT 使用PSMA-RADS 2.0版本

Gabriele Masselli1,2, Saadi Sollaku2, Cristina De Angelis2

  • 1Department of Radiological Sciences, Oncology and Anatomo-Pathology, "Sapienza" University of Rome, Piazzale Aldo Moro, 5, 00185 Rome, Italy.

Diagnostics (Basel, Switzerland)
|June 27, 2024
PubMed
概括

-68 PSMA PET/CT成像显示了复发前列腺癌的高检测率. 该PSMA-RADS版本2.0评分系统有效地分类恶性瘤,与PSA水平相关联.

关键词:
68Ga-PSMAMA 的使用情况.68Ga-PSMA 聚乙烯 / 聚乙烯 / 聚乙烯 / 聚乙烯这就是PSMA-RADS.生物化学复发的发生.前列腺癌是前列腺癌.

更多相关视频

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

相关实验视频

Last Updated: Jun 20, 2026

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

科学领域:

  • 核医学是一种核医学.
  • 在瘤学瘤学.
  • 放射学 放射学是一门学科.

背景情况:

  • 与标准方法相比,Ga-PSMA PET/CT是检测转移性复发性前列腺癌的优越成像方式.
  • 基于前列腺特异性膜抗原 (PSMA) 的成像为识别疾病复发提供了更高的灵敏度.

研究的目的:

  • 为了评估Ga-PSMA PET/CT在患者队列中的诊断性能.
  • 评估PSMA-RADS版本2.0分类系统对复发前列腺癌检测的有用性.

主要方法:

  • 对128名接受Ga-PSMA PET/CT以怀疑前列腺切除术后复发的患者进行了回顾性分析.
  • 患者使用PSMA-RADS版本2.0标准进行评估,3-5类被认为是恶性瘤阳性.

主要成果:

  • 复发前列腺癌的总体检测率为71%.
  • 检测率与前检查PSA水平有显著差异:38%的PSA<0.2 ng/mL,57%的PSA<0.2 ng/mL,77%的PSA<0.5-1 ng/mL,95%的PSA>1 ng/mL.
  • 通过PSMA-RADS v2.0分类,获得了与现有文献一致的结果.

结论:

  • Ga-PSMA PET/CT在检测前列腺癌复发方面表现出高效.
  • 该PSMA-RADS版本2.0提供了一个标准化的方法来解释这些扫描.
  • 成像性能与基线PSA水平有很强的相关性,有助于临床决策.